Viewing Study NCT04634669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-02-06 @ 5:58 AM
Study NCT ID: NCT04634669
Status: COMPLETED
Last Update Posted: 2023-03-07
First Post: 2020-11-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
Sponsor: Axsome Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Treatment Resistant Depression View
None Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AXS-05 View
None Treatment Resistant Depression View
None TRD View
None NMDA receptor View
None Refractory depression View
None Resistant depression View
None Depression View
None Major depression View
None Dextromethorphan View
None Bupropion View
None MDD View